Paris, France

Eliane Sobczak

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, National Institute of Health and Medical Research. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eliane Sobczak. Retrieved from https://idiyas.com/inventor/eliane-sobczak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eliane Sobczak and Vaccine Composition Innovation.

Introduction

Eliane Sobczak is an inventor associated with Paris, France. Her recorded patent concerns a composition designed for vaccine manufacture and reflects research into hepatitis B antigens.

Latest Patents

Sobczak is associated with 1 patent, titled “Composition Useful for the Fabrication of Vaccines.” The invention describes particles with immunogenic properties characteristic of the hepatitis B surface antigen, HBsAg, that also contain a receptor for polymerized human albumin. The particles are produced by transforming human or animal cells with a vector carrying DNA sequences for the S and pre-S regions of the hepatitis B viral genome, under the control of a promoter that enables effective transcription in those cells.

Career Highlights

The supplied career information associates Sobczak with the Institut Pasteur and the National Institute of Health and Medical Research. Her patent work addresses the production of vaccine-related particles through genetic transformation of cells.

Collaborations

Her listed collaborators include Pierre Tiollais and Yves Malpiece, both identified in the supplied information as deceased.

Conclusion

Eliane Sobczak’s recorded patent documents a vaccine-composition approach involving HBsAg-related particles and polymerized human albumin receptors, alongside research affiliations and collaborations in biomedical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…